SCHEMBL15426366

SCHEMBL15426366

CSc1ccccc1-c1nc2cc(C)ccc2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.54
SMN1; SMN2 Q16637 7/20 0.54
TP53 P04637 1/20 0.54
KDM4E B2RXH2 11/20 0.44
NPC1 O15118 9/20 0.44
RAB9A P51151 9/20 0.44
GAA P10253 7/20 0.44
ALDH1A1 P00352 7/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
NPSR1 Q6W5P4 2/20 0.41
GLA P06280 4/20 0.40
APP P05067 2/20 0.40
F2RL3 Q96RI0 1/20 0.40
HPGD P15428 2/20 0.40
DYRK1A Q13627 1/20 0.40
HCRTR1 O43613 1/20 0.40
ILK Q13418 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426367 0.85 MAPT (0.50) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL31038145 0.83 KDM4E (0.63) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL11953192 0.82 MAPT (0.50) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL23176467 0.82 MAPT (0.55) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL9952066 0.81 ILK (0.53) MAPTSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL29657204 0.81 MAPT (0.69) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL17265012 0.79 MAPT (0.57) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL10795782 0.77 MAPT (0.50) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL14438074 0.77 ALDH1A1 (0.56) MAPTSMN1; SMN2TP53KDM4ENPC1
SCHEMBL14699736 0.77 MAPT (0.59) MAPTSMN1; SMN2TP53KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 US disclosed
US-8853238-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-07 US disclosed
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF NR4A1, NR2C2, NR0B1 MAPT 4670/4885SMN1; SMN2 2358/4885TP53 4438/4885
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 MAPT 4635/4885SMN1; SMN2 2445/4885TP53 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.